Skip to main content

Top Left Menu

  • Careers
  • Media
  • Investors

What are you looking for?

Home

Top menu

You are here

Galderma Global

Choose another location

  • Argentina
  • Australia
  • Austria
  • Belgium
  • Brazil
  • Canada
  • Chile
  • Colombia
  • Czech Republic
  • Denmark
  • Finland
  • France
  • Germany
  • Hong Kong/Macau SAR, China
  • India
  • Italy
  • Japan
  • Korea
  • Mainland China
  • Mexico
  • Middle East
  • Netherlands
  • Nordic
  • Norway
  • Poland
  • Portugal
  • Russia
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Taiwan
  • Thailand
  • United Kingdom
  • United States
  • Venezuela
  • Contact us
  • Search

Main navigation

  • About us
    • At a glance
    • Our purpose
    • Our strategy
    • Injectable Aesthetics
    • Dermatological Skincare
    • Therapeutic Dermatology
    • Global presence
    • Executive Committee
    • Governance
    • Annual Report 2024
  • Skin Stories
    • Galderma skin stories
    • Skin Science
    • Beauty x Medicine
    • Podcasts
  • Innovation
    • Skin Science by Galderma
    • Bringing innovation to life
    • Partnering
    • Manufacturing
    • Early Access
  • Our brands
  • Sustainability
    • For our employees
    • For patients and consumers
    • For healthcare professionals and customers
    • For society
    • Governance oversight
    • Funding request for education and support activities
    • Our ESG Index
  • Media
  • Careers
  • Investors

Galderma Initiates Six New Studies, Increasing Company’s Commitment to Aesthetic Research and Innovation

Press release

Galderma Announces ASPIRE Rewards Program Reaches One Million Members

Press release

Galderma Partners with National Breast Cancer Foundation for 4th Annual Pink Day Event to Increase Breast Cancer Awareness

Press release

Fort Worth’s Galderma, Maker of Cetaphil, Presents the 4th Annual Wonder Run 5K and 1K Kids Waddle to Benefit Children’s Skin Disease Foundation

Press release

Galderma Announces FDA Approval of Restylane® Lyft For Midface Injection via Cannula

Press release

Galderma Announces New Collaborations with Top Aesthetic Professional Skincare Brands

Press release

Galderma Announces U.S. Collaboration with Nespresso®

Press release

A Decade of Dysport®: Galderma Celebrates 10 Years Since FDA Approval of Dysport in the U.S.

Press release

Cetaphil® Announces Partnership with Award-Winning Actress, Rachel Brosnahan

Press release

Fort Worth’s Galderma, Maker of Cetaphil, Presents the 5th Annual Wonder Run 5K and Kids 1K to Benefit Children’s Skin Disease Foundation

Press release

Pagination

  • Previous page Previous Page
  • Next page Next Page
Subscribe to U.S. release
  1. Home
  2. U.S. release

STAY CONNECTED

Follow us on Social Media for current news and patients stories

Instagram LinkedIn Icon Twitter Icon
© Galderma 2025

Footer menu 2

  • Terms of use
  • Cookie Policy
  • Privacy
  • Sitemap

Confirm navigation

You are about to leave the Galderma global site. Are you sure you want to leave this page?

Yes, thanks Go back